Mesothelioma UK awards £150,000 funding for new research studies

Mesothelioma UK, the national asbestos-related cancer charity, is supporting five new research studies with funding from its first grant round since successfully becoming a member of the Association of Medical Research Charities. The studies will be conducted by research teams based in either NHS Trusts, NHS Foundations and UK universities, and will focus on issues affecting the treatment and care of mesothelioma patients.

Each of the following research studies have been successful in this round of grant funding:

  • North Tees and Hartlepool NHS Foundation – Understanding the patient journey for those with mesothelioma: a review
  • Northumbria Healthcare NHS Foundation Trust – Diet and physical activity in patients with mesothelioma
  • University of the Highlands and Islands – Improving the patient diagnostic pathway for mesothelioma
  • University of Leicester – A test to diagnose and predict clinical outcomes in mesothelioma
  • University of Sheffield – Improving symptom control in mesothelioma

Mesothelioma UK is committed to supporting research into all aspects of treatment and care related to mesothelioma and has funded research and audit since 2015, both independently and through partner organisations. The charity offers a range of grant opportunities to universities, medical schools and research institutes within the UK and Northern Ireland that fund research that explores patients’ experience of care, through to research on patient diagnosis, treatments and outcomes of care. All of the grants are rigorously reviewed by the charity’s Research and Audit Scientific Committee to ensure that they are conducting quality research into areas that will see real benefit to mesothelioma patients.

Liz Darlison, Mesothelioma UK Chief Executive commented: “Our mission is to fund world-class mesothelioma research that makes a significant impact on patient treatment and care, outcomes and patient experiences.

“We’re delighted to be able to award these five research teams the funding to enable them to carry out their important studies and we look forward to seeing the results and impacts of the research. We are extremely grateful to the charity’s fundraisers and donors; without their support, these grants would not be possible.”

Access to immunotherapy update

As you may be aware from previous issues of our magazine, first line immunotherapy (nivolumab and ipilimumab) for the treatment of mesothelioma is currently under consideration by the National Institute for Health and Care Excellence (NICE) following the results of...

Mesothelioma UK partners with Healthinote

Mesothelioma UK has joined Healthinote, an online digital platform allowing doctors, nurses and pharmacists to find and share reliable health information with their patients. Used by over 3,000 GP practices in the UK, Heathinote enables people to be given an...

New Chemotherapy Booklet

Our new booklet Chemotherapy for Mesothelioma addresses key questions people with mesothelioma may have if they are offered chemotherapy. “Whether to accept chemotherapy is not always a straightforward decision for people with mesothelioma. Our new booklet can help...

Mesothelioma UK appoints new Head of Nursing

Leah Taylor has been appointed as the new Head of Nursing for Mesothelioma UK. In this role, Leah will work closely with the charity’s operational team and trustees, and will provide strategic leadership of the charity’s UK network of 34 Clinical Nurse Specialists....

PIF TICK certification for our patient information

We know how overwhelming a diagnosis of mesothelioma can be, and how good written information can play a vital part in helping people make informed choices. This is why we’re so pleased to have been recertified under the PIF TICK scheme, demonstrating our commitment...